Literature DB >> 10189136

Demographics, family histories, and psychological characteristics of prostate carcinoma screening participants.

K L Taylor1, J DiPlacido, W H Redd, K Faccenda, L Greer, A Perlmutter.   

Abstract

BACKGROUND: The goals of this study were to 1) understand the reasons that men seek prostate carcinoma screening, in light of the ongoing medical controversy surrounding screening; and 2) assess the level of psychological distress and perceived risk among men seeking screening, and whether or not these variables were dependent on a man's family history of prostate carcinoma.
METHODS: The subjects were 126 men (40% had a family history of prostate carcinoma) who participated in a free prostate carcinoma detection program. Questionnaires, which were completed prior to prostate carcinoma screening, included demographic and medical information, reasons for screening participation, general and cancer-related psychological distress, and perceived risk for prostate carcinoma.
RESULTS: Among both family history groups, self-referral was the most common reason for attending the screening, compared with receiving a recommendation from a health professional or from a friend or family member. Men with a positive family history were not more distressed than those without a family history; but as the authors predicted, men with a positive family history of prostate carcinoma did report higher levels of perceived risk relative to those without a family history. In addition, an interaction revealed that psychological distress was greater among men with a family history only among those who also reported elevated perceived risk.
CONCLUSIONS: Similar to other prostate carcinoma screening programs, men in the current sample largely elected to attend the screening on their own. Furthermore, although perceived risk was higher among men with a family history compared with those without a family history, psychological distress was greater among men with a family history only among those who also reported elevated perceived risk. Thus, among men with a family history of the disease, perceived risk may be a marker of elevated psychological distress. Screening programs should assess family history and perceived risk because of the potential psychological implications for screening participants.

Entities:  

Mesh:

Year:  1999        PMID: 10189136     DOI: 10.1002/(sici)1097-0142(19990315)85:6<1305::aid-cncr13>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  [Is the prostate cancer screening behaviour of men with familial predisposition predictable?].

Authors:  T Paiss; D Kahn; R Küfer; C Maier; W Vogel; J E Gschwend; R E Hautmann; K Herkommer
Journal:  Urologe A       Date:  2005-04       Impact factor: 0.639

2.  A model of disease-specific worry in heritable disease: the influence of family history, perceived risk and worry about other illnesses.

Authors:  Terry A DiLorenzo; Julie Schnur; Guy H Montgomery; Joel Erblich; Gary Winkel; Dana H Bovbjerg
Journal:  J Behav Med       Date:  2006-02-10

3.  The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes.

Authors:  Floyd J Fowler; Michael J Barry; Beth Walker-Corkery; Jean-Francois Caubet; David W Bates; Jeong Min Lee; Alison Hauser; Mary McNaughton-Collins
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

4.  Awareness and use of the prostate-specific antigen test among African-American men.

Authors:  Louie E Ross; Robert J Uhler; Kymber N Williams
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

5.  Effects of a randomized trial comparing standard and enhanced counseling for men at high risk of prostate cancer as a function of race and monitoring style.

Authors:  Pagona Roussi; Suzanne M Miller; Veda N Giri; Elias Obeid; Kuang-Yi Wen; Erin K Tagai; John Scarpato; Laura Gross; Gem Roy
Journal:  J Health Psychol       Date:  2016-10-10

6.  Perceived risk and worry about prostate cancer: a proposed conceptual model.

Authors:  Julie B Schnur; Terry A DiLorenzo; Guy H Montgomery; Joel Erblich; Gary Winkel; Simon J Hall; Dana H Bovbjerg
Journal:  Behav Med       Date:  2006       Impact factor: 3.104

7.  Patient-Provider Communication About Prostate Cancer Screening and Treatment: New Evidence From the Health Information National Trends Survey.

Authors:  Soumitra S Bhuyan; Aastha Chandak; Niodita Gupta; Sudhir Isharwal; Chad LaGrange; Asos Mahmood; Dan Gentry
Journal:  Am J Mens Health       Date:  2016-07-07

8.  Fostering informed decisions: a randomized controlled trial assessing the impact of a decision aid among men registered to undergo mass screening for prostate cancer.

Authors:  Randi M Williams; Kimberly M Davis; George Luta; Sara N Edmond; Caroline S Dorfman; Marc D Schwartz; John Lynch; Chiledum Ahaghotu; Kathryn L Taylor
Journal:  Patient Educ Couns       Date:  2013-01-26

9.  A randomized trial comparing web-based decision aids on prostate cancer knowledge for African-American men.

Authors:  Gary L Ellison; Sally P Weinrich; Mimi Lou; Hongyan Xu; Isaac J Powell; Claudia R Baquet
Journal:  J Natl Med Assoc       Date:  2008-10       Impact factor: 1.798

10.  Why men with prostate cancer want wider access to prostate specific antigen testing: qualitative study.

Authors:  Alison Chapple; Sue Ziebland; Sasha Shepperd; Rachel Miller; Andrew Herxheimer; Ann McPherson
Journal:  BMJ       Date:  2002-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.